Opioid Use and Misuse Resource Center

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize misuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug misuse prevention, education, and assistance.  

Opioid News
January 23, 2020
Evidence Based Practice: Podcast and Literature Series

APhA has partnered with iForumRx, an interactive web-based community for Ambulatory Care pharmacy specialists, to produce a line of innovative and interactive recertification products. This series will feature succinct commentaries about practice-changing evidence through a series of podcasts,…

Read More
January 6, 2020
New report frames opioid prescribing guidelines for acute pain

FDA tasked NASEM with developing the report in order for medical groups, health care providers, and others to evaluate current and future opioid prescribing to support a clinical practice guideline and to identify gaps in the evidence where future research is needed. The report is meant to serve as…

Read More
November 22, 2019
Loperamide will now come in limited-dose packaging

The changes apply to the packaging for tablet and capsule forms of the brand-name OTC antidiarrheal medications Imodium A-D, Imodium Multi-Symptom Relief, and Be Health Loperamide HCI Capsules, according to an FDA safety communication. Each pack will now contain no more than 48 mg of loperamide,…

Read More
July 19, 2019
AMA Opioid Task Force releases recommendations to increase treatment access

AMA’s Opioid Task Force released recommendations in May focused on prior authorization, step therapy, and other administrative barriers that prevent patients from being able to access appropriate and timely medication-assisted therapy (MAT) for treatment of opioid use disorder.  “Once a patient…

Read More
June 25, 2019
Shorter duration opioid prescriptions plus education could be better for patients after surgery

A total of 264 patients were divided into three groups: 109 were prescribed 50 opioid tablets after surgery, 78 patients were prescribed 30 tablets and received education before surgery on appropriate opioid use and alternative pain control strategies, and 77 patients received 30 tablets and no…

Read More
May 20, 2019
How common is inappropriate use of transmucosal immediate-release fentanyl?

In a recent issue of JAMA, Rollman and colleagues evaluated almost 5,000 pages of FDA documents obtained via a Freedom of Information Act to assess whether the REMS program for TIRF products was meeting its goals. Specifically, the researchers reviewed 6 years of REMS data from 2012 to 2017 for the…

Read More